Atrys Health, S.A. (FRA:A2T)

Market Cap	219.37M -0.7%
Revenue (ttm)	144.31M -33.8%
Net Income	-100.30M
EPS	-1.32
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	272
Open	2.540
Previous Close	2.750
Day's Range	2.540 - 2.770
52-Week Range	2.210 - 3.390
Beta	n/a
RSI	49.96
Earnings Date	Jun 22, 2026

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Medical Laboratories
• Founded: 2007
• Employees: 1,985
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: A2T

Financial Performance

In 2025, Atrys Health's revenue was 144.31 million, a decrease of -33.83% compared to the previous year's 218.10 million. Losses were -100.30 million, 215.7% more than in 2024.